Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXT3DN
|
||||
Drug Name |
3-Benzyl-1-(3H-imidazol-4-ylmethyl)-4-methanesulfonyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonitrile
|
||||
Synonyms |
CHEMBL118181
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H23N5O2S
|
||||
Canonical SMILES |
CS(=O)(=O)N1Cc2cc(ccc2N(Cc3c[nH]cn3)C[C@H]1Cc4ccccc4)C#N
|
||||
InChI |
InChI=1S/C22H23N5O2S/c1-30(28,29)27-13-19-9-18(11-23)7-8-22(19)26(14-20-12-24-16-25-20)15-21(27)10-17-5-3-2-4-6-17/h2-9,12,16,21H,10,13-15H2,1H3,(H,24,25)/t21-/m1/s1
|
||||
InChIKey |
KMMDHGFUBJRYRM-OAQYLSRUSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.